Pure Monograph vs IQVIA
IQVIA is one of the largest contract research organizations in the world. Pure Monograph is a source-traced monograph engine. The two sit in different categories and solve different problems; direct head-to-head comparison misses the point.
Short answer. IQVIA is an enterprise CRO and data provider. Pure Monograph assembles the scientific case from public evidence and marks where that record ends. They overlap only at the edges — most sponsors who use Pure Monograph either have no CRO yet or are already retaining IQVIA for trial operations.
At a glance
| Dimension | Pure Monograph | IQVIA |
|---|---|---|
| Primary deliverable | Asset intelligence, Trial Autopsy, Trial Counterfactual | Full-service clinical trials, real-world evidence, commercial analytics |
| Category | Molecule intelligence | Publicly traded CRO (NYSE: IQV) |
| Regulatory output | Cited reports with gaps marked; not a submission publisher | Full regulatory submissions via consulting engagement |
| Pricing | Free: one named-molecule report. No upload. Enterprise: team workspace. | Enterprise contracts (typical CRO engagements start at six figures and scale up) |
| Engagement model | Self-serve report, then ask us for a team workspace | Consulting engagement with dedicated project teams |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | IQVIA Holdings Inc., Durham NC, USA (NYSE: IQV) |
Where each wins
IQVIA is the right tool when you are outsourcing an actual trial program, buying longitudinal patient-level data, or running commercial strategy at global scale. The price reflects that scope.
Pure Monograph is the right tool when a CEO, CSO, or Head of R&D needs the public evidence assembled on a named program — asset intelligence, Trial Autopsy, Trial Counterfactual — without a CRO retainer.
Using both together
Common pattern: sponsor retains IQVIA for clinical trial operations and pharmacovigilance. Internal program leads use Pure Monograph to assemble the scientific case before they spend on the bench or on another consulting workstream. The two layers rarely touch the same artifact.
Frequently asked questions
Is Pure Monograph competitive with IQVIA?
Only at the narrow edge where a team wants public evidence assembled before they hire a CRO. The bulk of IQVIA's business is clinical operations and data at enterprise scale.
What is IQVIA, in one line?
IQVIA (NYSE: IQV) is the publicly traded CRO formed from the IMS Health and Quintiles merger, offering clinical trials, real-world evidence, and commercial analytics at enterprise scale.
When would I use one versus the other?
Use IQVIA when you need to outsource a full trial program or run global commercial analytics. Use Pure Monograph when you need a source-traced report or trial analysis without a consulting retainer.
Do you replace CRO services?
No. The platform does not conduct trials, manage sites, or sign clinical agreements. It produces source-traced reports that sponsors or CROs use as inputs.